Triple Therapy in Asthma - Your Questions Answered

Trending3.5(New)

Asthma is a chronic respiratory condition characterised by airway inflammation, bronchoconstriction, and airway hyperresponsiveness. While most patients achieve control with standard therapies such as inhaled corticosteroids (ICS) combined with long‑acting beta‑agonists (LABA), a subset of individuals with moderate to severe disease continue to experience symptoms and exacerbations despite appropriate treatment. For these patients, guideline‑informed step‑up therapy may include adding a long‑acting muscarinic antagonist (LAMA) to their regimen—creating what is known as triple therapy (ICS + LABA + LAMA). Triple therapy aims to provide broader bronchodilation and enhanced anti‑inflammatory effects, targeting different pathways within the airway.

7 Modules1 hour
$169$0
Triple Therapy in Asthma - Your Questions Answered

Learning Outcomes

What you'll learn

  • Describe the components and mechanisms of triple therapy in asthma.
  • Identify appropriate clinical indications for triple therapy.
  • Assess patient suitability for step‑up to triple therapy.
  • Implement triple therapy with attention to inhaler technique and adherence.
  • Monitor treatment efficacy and adjust therapy based on clinical response.
  • Counsel patients effectively about expected benefits, risks, and correct inhaler use.

Modules

Module 1

What is Triple Therapy in Asthma?

Module 2

When to Consider Triple Therapy

Module 3

Evidence and Outcomes with Triple Therapy

Module 4

Implementing Triple Therapy in Practice

Module 5

Monitoring and Adjusting Triple Therapy

Module 6

Patient Education and Shared Decision‑Making

Module 7

Summary

Top reviews

No reviews yet.

You May Also Like

Learn Anytime
Anywhere

Experience the next level of learning with the Care Learning app. Available on Android and iOS.

Download on the App StoreGet it on Google Play

Come and Work
with Us!

Join us as a healthcare trainer providing practical sessions to professionals and workers.

Apply for Trainer Role

In-Person Practical
Healthcare Training

Enroll in our accredited, hands-on practical training sessions to deliver better patientcentred care.

Apply for Training

Refer &
Earn Rewards.

Invite healthcare professionals to join Care Learning and earn rewards for every successful referral.

1 / 4

Frequently Asked Questions

A maintenance regimen combining an inhaled corticosteroid (ICS), long‑acting beta‑agonist (LABA), and long‑acting muscarinic antagonist (LAMA).

When asthma is not controlled with medium‑ or high‑dose ICS/LABA despite good adherence.

Yes, single‑inhaler triple combinations are available and may improve adherence.

Improved lung function and reduced exacerbations in selected patients.

No. It’s a step‑up option after dual therapy is insufficient.

Proper technique ensures optimal drug delivery and therapeutic effect.